100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19Niyati Lobo, Ashish M. Kamat, Joshua J. Meeks et al.|Nature Reviews Urology|2021Cited by 154
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta TumorsKelly K. Bree, Ashish M. Kamat, Patrick J. Hensley et al.|The Journal of Urology|2022Cited by 22
Reply by AuthorsKelly K. Bree, Ashish M. Kamat, Colin P. Dinney et al.|The Journal of Urology|2022Cited by 0